Sanofi's net sales rise 6.8% in Q4 to €9.6B

Thursday, 06. February 2020 07:43

French pharmaceutical giant Sanofi S.A. said on Thursday in its latest earnings report that the net sales in the fourth quarter of 2019 increased by 6.8% year-over-year, reaching the figure of €9.6 billion driven mainly by vaccines sales rise of 22%. Meanwhile, the company reported loss per share of €0.01 in the same period on net loss of €10 million.

For the whole of 2019, the pharma giant's top line came in at €36.12 billion, rising 4% on an annual scale, while earnings per share landed at €2.24 on net income of €2.8 billion, marking a 34% decrease compared to 2018.

"The acceleration in sales performance was mainly driven by the impressive growth of Dupixent," whose sales reached €2 billion, Sanofi CEO Paul Hudson said commenting on earnings. "At the same time, our sharpened focus on operating and financial efficiencies helped us to deliver margin expansion and significant cash flow improvement," he added.

Related Links: Sanofi S.A.Sanofi S.A.
Breaking the News / GG